BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,080 filers reported holding BAXTER INTL INC in Q3 2020. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $674,451 | -19.8% | 17,871 | -3.2% | 0.02% | -19.0% |
Q2 2023 | $841,128 | +12.3% | 18,462 | 0.0% | 0.02% | +5.0% |
Q1 2023 | $748,818 | -25.3% | 18,462 | -6.1% | 0.02% | -31.0% |
Q4 2022 | $1,002,171 | +193.0% | 19,662 | +209.3% | 0.03% | +141.7% |
Q3 2022 | $342,000 | +1528.6% | 6,357 | +2548.8% | 0.01% | +1100.0% |
Q4 2021 | $21,000 | +10.5% | 240 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $19,000 | 0.0% | 240 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $19,000 | 0.0% | 240 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $19,000 | 0.0% | 240 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $19,000 | 0.0% | 240 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $19,000 | -9.5% | 240 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $21,000 | +10.5% | 240 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $19,000 | -91.5% | 240 | -91.0% | 0.00% | -92.9% |
Q4 2019 | $223,000 | +3.7% | 2,673 | +8.8% | 0.01% | -6.7% |
Q3 2019 | $215,000 | +975.0% | 2,456 | +923.3% | 0.02% | +650.0% |
Q1 2019 | $20,000 | +5.3% | 240 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $19,000 | +5.6% | 240 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $18,000 | +12.5% | 240 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $16,000 | -79.7% | 240 | -81.7% | 0.00% | -81.8% |
Q2 2017 | $79,000 | +7800.0% | 1,315 | – | 0.01% | – |
Q2 2016 | $1,000 | 0.0% | 0 | – | 0.00% | – |
Q1 2016 | $1,000 | -99.6% | 0 | -100.0% | 0.00% | -100.0% |
Q4 2015 | $278,000 | -24.0% | 7,283 | -34.6% | 0.09% | -24.3% |
Q3 2015 | $366,000 | -47.6% | 11,129 | +11.5% | 0.12% | -48.0% |
Q2 2015 | $698,000 | +69700.0% | 9,979 | – | 0.22% | – |
Q1 2015 | $1,000 | 0.0% | 0 | – | 0.00% | – |
Q3 2014 | $1,000 | 0.0% | 0 | – | 0.00% | – |
Q1 2014 | $1,000 | -95.2% | 0 | -100.0% | 0.00% | -100.0% |
Q3 2013 | $21,000 | +2000.0% | 305 | – | 0.01% | +900.0% |
Q2 2013 | $1,000 | – | 0 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |